Skip to main content
. 2021 Jun 23;11(7):412. doi: 10.3390/metabo11070412

Table 1.

Significant (VIP) lipids obtained by PLS-DA model on the set of all detected plasma lipids.

Lipid Name Adduct Retention Time m/z Fold Change
A-K D-K
FA (20:2) [M − H] 5.408 307.2636 0.70 0.39
FA (20:3) [M − H] 4.316 305.2479 0.64 0.31
FA (20:3) [M − H] 4.669 305.2479 0.73 0.32
FA (20:4). [M − H] 3.632 303.2324 0.76 0.48
FA (20:5) [M − H] 2.861 301.2166 0.68 0.39
FA (22:4) [M − H] 4.741 331.2665 0.74 0.46
FA (22:5) [M − H] 3.794 329.2481 0.51 0.31
FA (22:5) [M − H] 4.118 329.2481 0.58 0.31
FA (22:6) [M − H] 3.235 327.2325 0.58 0.38
FAHFA (14:0/16:2) [M − H] 3.439 477.3908 0.27 0.08
FAHFA (16:1/18:3) [M − H] 3.614 529.4225 0.34 0.14
FAHFA (18:1/20:3) [M − H] 5.205 585.4851 0.52 0.21
FAHFA (18:2/20:4) [M − H] 3.932 581.4535 0.79 0.41
FAHFA (20:4/18:3) [M − H] 3.626 579.4376 0.53 0.23
LPC (20:5) [M + H]+ 2.239 542.3265 1.23 0.63
LPC (22:5) [M + H]+ 2.435 570.3590 1.97 0.48
LPC (22:6) [M + H]+ 2.020 568.3428 0.85 0.42
LPC (22:6) [M + H]+ 2.450 568.3420 1.24 0.56
LPE (18:2) [M − H] 2.315 476.2774 1.39 0.67
LPE (20:4) [M − H] 2.218 500.2774 1.13 0.46
LPE (22:6) [M − H] 2.092 524.2771 0.97 0.48
LPI (18:1) [M − H] 2.224 597.3032 2.09 1.13
LPI (18:2) [M − H] 1.823 595.2878 2.09 1.18
TG (14.0_16.1_20.3) [M + NH4]+ 12.94 844.7394 0.79 1.78
TG (16:0_16:1_18:0) [M + Na]+ 13.33 855.7420 0.80 3.46
TG (16:0_18:2_18:3) [M + NH4]+ 13.00 870.7544 0.70 1.77
TG (16:0_18:2_22:6) [M + NH4]+ 12.99 920.7687 0.71 1.49
TG (17:1_17:2_19:0) [M + NH4]+ 13.85 888.8015 0.73 1.60
FA (16:1) [M − H] 3.617 253.2168 0.55 0.34
FA (17:1) [M − H] 4.325 267.2325 0.61 0.35

FA—fatty acid; FAHFA—fatty acyl ester of hydroxy fatty acid; LPC—lysophocholine; LPE—lysophoetanolamine; LPI—lysophoinositol; TG—triacylglycerol.